| 000 | 01816 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513160244.0 | ||
| 264 | 0 | _c19990225 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a0021-9150 | ||
| 024 | 7 |
_a10.1016/s0021-9150(98)00151-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aContacos, C | |
| 245 | 0 | 0 |
_aCholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin. _h[electronic resource] |
| 260 |
_bAtherosclerosis _cNov 1998 |
||
| 300 |
_a87-98 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aApolipoproteins B _xblood |
| 650 | 0 | 4 |
_aCarrier Proteins _xblood |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 | _aCholesterol Ester Transfer Proteins |
| 650 | 0 | 4 |
_aCholesterol Esters _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDietary Fats _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aFasting _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlycoproteins |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aHypercholesterolemia _xblood |
| 650 | 0 | 4 |
_aLipoproteins, VLDL _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPostprandial Period |
| 650 | 0 | 4 |
_aPravastatin _xtherapeutic use |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aBarter, P J | |
| 700 | 1 | _aVrga, L | |
| 700 | 1 | _aSullivan, D R | |
| 773 | 0 |
_tAtherosclerosis _gvol. 141 _gno. 1 _gp. 87-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0021-9150(98)00151-8 _zAvailable from publisher's website |
| 999 |
_c9826316 _d9826316 |
||